Home About Us News Screening Diagnosis Treatment Patient Information Education
Contact Us
Educational Articles
Breast Cancer FAQs
Breast Self Exams
Breast Pain / Mastalgia
BRCA Testing
Fibrocystic Breast Changes
Open Breast Biopsies
Benefits of SAVI
Molecular Subtyping
Adjuvant Therapy
HALO Breast Pap Test
Inflammatory Breast Cancer
Locally Advanced Breast Cancer
Radiation Treatment for Early Stage
Sentinel Lymph Node Biopsy
Stereotactic Core Needle Biopsy
Non-Invasive Breast Cancer
No Prissy Shoes
Clinical Trials
American Society of Breast Surgery Mammo
University of Louisville Sentinel Lymph
NSABP, B39, B40 Clinical Trials
Taylor Rx Trial
Types of Breast Cancer
In Situ Breast Cancer
Invasive Breast Cancer
Locally Advanced Breast Cancer
Inflammatory Breast Cancer
Metastatic Breast Cancer
Frequently Asked Questions
What is Breast Pain/Mastalgia?
What is Lobular Carcinoma is Situ?
What is Atypical Ductal Hyperplasia?
What are Estrogen and Progesterone recep
What is the HER-2/neu test?
What is Whole Breast Irradiation?
What is Partial Breast Irradiation?
What are the reconstruction options?
Why do we give chemotherapy?
What is Tamoxifen?
What Is Ductal Carcinoma in Situ?
Are there prognostic indicators?
Are there different types?
What is Nipple Discharge?
What is Breast Cancer?
How does Breast Cancer spread?
Who gets Breast Cancer?
What are the chances?
Does race play a role in incidence?
What are fibrocystic changes?
What are the physical signs?
How is Breast Cancer staged?
What are the Aromatase inhibitors?
HALO Breast Pap Test
The key to surviving breast cancer is with early detection. If it is found in its early stages when it is still confined to the breast, the 5 year survival is close to 100%. Until now, the only way to diagnose breast cancer was through mammography, ultrasound, MRI, and physical exam. The ability to identify high risk patients for the future development of breast cancer has been an inconsistent science at best.

We have known for decades that Nipple Aspirate Fluid (NAF) can be an indicator of a woman’s breast health. Unfortunately, there has not been a consistent way to collect and analyze this fluid in order to identify high risk patients (ie. Ductal Lavage, Random periareolar fine needle aspiration). The FDA has recently approved the HALO® Breast Pap Test for collecting NAF. This test is a five minute, non-invasive test that can help determine a woman’s risk of breast cancer years earlier than a mammogram...Read more here.